Chapter 16 Antiangiogenic Photodynamic Therapy with Targeted Liposomes

Methods in Enzymology

Volumn 465, Issue C, 2009, Pages 313-330

  Oku, Naoto ^a   Ishii, Takayuki ^a  

^a UNIVERSITY OF SHIZUOKA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANYLPROLYLARGINYLPROLYLGLYCINE; ALANYLPROLYLARGINYLPROLYLGLYCINE PEGYLATED LIPOSOMAL BENZOPORPHYRIN DERIVATIVE MONOACID RING A; BENZOPORPHYRIN DERIVATIVE; GLYCINE DERIVATIVE; LIPOSOME; PEGYLATED LIPOSOMAL BENZOPORPHYRIN DERIVATIVE MONOACID RING A; PENTOBARBITAL; UNCLASSIFIED DRUG; VERTEPORFIN; ANGIOGENESIS INHIBITOR; MACROGOL DERIVATIVE; PORPHYRIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIANGIOGENIC ACTIVITY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG FORMULATION; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; INJECTION; IRRADIATION; LASER; MALE; MOLECULAR PROBE; MOUSE; NANOENCAPSULATION; NONHUMAN; PARTICLE SIZE; PHOTODYNAMIC THERAPY; PHOTOSENSITIZATION; PRIORITY JOURNAL; REVIEW; TUMOR; TUMOR GROWTH; ANIMAL; APOPTOSIS; ARTICLE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; NEOVASCULARIZATION (PATHOLOGY); PHOTOCHEMOTHERAPY; TISSUE DISTRIBUTION; TUMOR CELL LINE;

ANGIOGENESIS INHIBITORS; ANIMALS; APOPTOSIS; CELL LINE, TUMOR; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; LIPOSOMES; MICE; NEOVASCULARIZATION, PATHOLOGIC; PHOTOCHEMOTHERAPY; POLYETHYLENE GLYCOLS; PORPHYRINS; TISSUE DISTRIBUTION;

EID: 71549121341     PISSN: 00766879     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0076-6879(09)65016-3     Document Type: Review

References (26)

1. Arote R.B., Hwang S.K., Yoo M.K., Jere D., Jiang H.L., Kim Y.K., Choi Y.J., Nah J.W., Cho M.H., and Cho C.S. Biodegradable poly(ester amine) based on glycerol dimethacrylate and polyethylenimine as a gene carrier. J. Gene Med. 10 (2008) 1223-1235
2. Chen B., Crane C., He C., Gondek D., Agharkar P., Savellano M.D., Hoopes P.J., and Pogue B.W. Disparity between prostate tumor interior versus peripheral vasculature in response to verteporfin-mediated vascular-targeting therapy. Int. J. Cancer 123 (2008) 695-701
3. Dolmans D.E., Kadambi A., Hill J.S., Waters C.A., Robinson B.C., Walker J.P., Fukumura D., and Jain R.K. Vascular accumulation of a novel photosensitizer, MV6401, causes selective thrombosis in tumor vessels after photodynamic therapy. Cancer Res. 62 (2002) 2151-2156
4. Dolmans D.E., Kadambi A., Hill J.S., Flores K.R., Gerber J.N., Walker J.P., Borel Rinkes I.H., Jain R.K., and Fukumura D. Targeting tumor vasculature and cancer cells in orthotopic breast tumor by fractionated photosensitizer dosing photodynamic therapy. Cancer Res. 62 (2002) 4289-4294
5. Green A.E., and Rose P.G. Pegylated liposomal doxorubicin in ovarian cancer. Int. J. Nanomed. 1 (2006) 229-239
6. Huang Z., Xu H., Meyers A.D., Musani A.I., Wang L., Tagg R., Barqawi A.B., and Chen Y.K. Photodynamic therapy for treatment of solid tumors-Potential and technical challenges. Technol. Cancer Res. Treat. 7 (2008) 309-320
7. Ichikawa K., Takeuchi Y., Yonezawa S., Hikita T., Kurohane K., Namba Y., and Oku N. Antiangiogenic photodynamic therapy (PDT) using Visudyne causes effective suppression of tumor growth. Cancer Lett. 205 (2004) 39-48
8. Ichikawa K., Hikita T., Maeda N., Takeuchi Y., Namba Y., and Oku N. PEGylation of liposome decreases the susceptibility of liposomal drug in cancer photodynamic therapy. Biol. Pharm. Bull. 27 (2004) 443-444
9. Ichikawa K., Hikita T., Maeda N., Yonezawa S., Takeuchi Y., Asai T., Namba Y., and Oku N. Antiangiogenic photodynamic therapy (PDT) by using long-circulating liposomes modified with peptide specific to angiogenic vessels. Biochim. Biophys. Acta 1669 (2005) 69-74
10. Ishida T., Harashima H., and Kiwada H. Liposome clearance. Biosci. Rep. 22 (2002) 197-224
11. Kurohane K., Tominaga A., Sato K., North J.R., Namba Y., and Oku N. Photodynamic therapy targeted to tumor-induced angiogenic vessels. Cancer Lett. 167 (2001) 49-56
12. Maeda N., Miyazawa S., Shimizu K., Asai T., Yonezawa S., Kitazawa S., Namba Y., Tsukada H., and Oku N. Enhancement of anticancer activity in antineovascular therapy is based on the intratumoral distribution of the active targeting carrier for anticancer drugs. Biol. Pharm. Bull. 29 (2006) 1936-1940
13. Matsuura M., Yamazaki Y., Sugiyama M., Kondo M., Ori H., Nango M., and Oku N. Polycation liposome-mediated gene transfer in vivo. Biochim. Biophys. Acta 1612 (2003) 136-143
14. Oku N., Saito N., Namba Y., Tsukada H., Dolphin D., and Okada S. Application of long-circulating liposomes to cancer photodynamic therapy. Biol. Pharm. Bull. 20 (1997) 670-673
15. Oku N., Yamazaki Y., Matsuura M., Sugiyama M., Hasegawa M., and Nango M. A novel non-viral gene transfer system, polycation liposomes. Adv. Drug Deliv. Rev. 52 (2001) 209-218
16. Oku N., Asai T., Watanabe K., Kuromi K., Nagatsuka M., Kurohane K., Kikkawa H., Ogino K., Tanaka M., Ishikawa D., Tsukada H., Momose M., et al. Anti-neovascular therapy using novel peptides homing to angiogenic vessels. Oncogene 21 (2002) 2662-2669
17. Ol'shevskaya V.A., Nikitina R.G., Savchenko A.N., Malshakova M.V., Vinogradov A.M., Golovina G.V., Belykh D.V., Kutchin A.V., Kaplan M.A., Kalinin V.N., Kuzmin V.A., and Shtil A.A. Novel boronated chlorin e6-based photosensitizers: Synthesis, binding to albumin and antitumour efficacy. Bioorg. Med. Chem. 17 (2009) 1297-1306
18. Osaki T., Hoshino S., Hoshino Y., Takagi S., Okumura M., Kadosawa T., and Fujinaga T. Clinical pharmacokinetics of anti-angiogenic photodynamic therapy with benzoporphyrin derivative monoacid ring-A in dogs having naturally occurring neoplasms. J. Vet. Med. A Physiol. Pathol. Clin. Med. 53 (2006) 108-112
19. Pastorino F., Brignole C., Marimpietri D., Cilli M., Gambini C., Ribatti D., Longhi R., Allen T.M., Corti A., and Ponzoni M. Vascular damage and anti-angiogenic effects of tumor vessel-targeted liposomal chemotherapy. Cancer Res. 63 (2003) 7400-7409
20. Pavani C., Uchoa A.F., Oliveira C.S., Iamamoto Y., and Baptista M.S. Effect of zinc insertion and hydrophobicity on the membrane interactions and PDT activity of porphyrin photosensitizers. Photochem. Photobiol. Sci. 8 (2009) 233-240
21. Shah G.K., Sang D.N., and Hughes M.S. Verteporfin combination regimens in the treatment of neovascular age-related macular degeneration. Retina 29 (2009) 133-148
22. Shimizu K., and Oku N. Cancer anti-angiogenic therapy. Biol. Pharm. Bull. 27 (2004) 599-605
23. Takeuchi Y., Kurohane K., Ichikawa K., Yonezawa S., Nango M., and Oku N. Induction of intensive tumor suppression by anti-angiogenic photodynamic therapy using polycation-modified liposomal photosensitizer. Cancer 97 (2003) 2027-2034
24. Takeuchi Y., Kurohane K., Ichikawa K., Yonezawa S., Ori H., Koishi T., Nango M., and Oku N. Polycation liposome enhances the endocytic uptake of photosensitizer into cells in the presence of serum. Bioconjug. Chem. 14 (2003) 790-796
25. Vittar N.B., Prucca C.G., Strassert C., Awruch J., and Rivarola V.A. Cellular inactivation and antitumor efficacy of a new zinc phthalocyanine with potential use in photodynamic therapy. Int. J. Biochem. Cell Biol. 40 (2008) 2192-2205
26. Yamazaki Y., Nango M., Matsuura M., Hasegawa Y., Hasegawa M., and Oku N. Polycation liposomes, a novel nonviral gene transfer system, constructed from cetylated polyethylenimine. Gene Ther. 7 (2000) 1148-1155